Why is routine prolonged hyperventilation avoided in severe TBI, and when is it used?

Why is routine prolonged hyperventilation avoided in severe TBI, and when is it used?

• A. It reduces cerebral blood flow and risks ischemia; used only as a temporizing measure for impending herniation with target PaCO2 ~30-35 mmHg for short duration
• B. It increases cerebral blood flow and is used routinely in all patients
• C. It has no effect on cerebral blood flow and is not used
• D. It improves neuronal recovery and is used as standard therapy

Answer: (A)

The key idea is that carbon dioxide levels directly control cerebral vessel tone and thus intracranial pressure, but at the cost of cerebral blood flow. Lowering PaCO2 causes cerebral vasoconstriction, which reduces cerebral blood volume and ICP. However, this also reduces blood flow to potentially injured brain tissue, increasing the risk of ischemia if used for too long. Because of that balance, hyperventilation is not used routinely or long-term in severe TBI. It is reserved as a temporary, crisis-management maneuver when there are signs of impending herniation, to rapidly lower ICP while definitive therapies are pursued. The typical target in this urgent setting is a PaCO2 of about 30–35 mmHg for a short duration, after which ventilation is normalized to avoid ongoing ischemic risk.

The key idea is that carbon dioxide levels directly control cerebral vessel tone and thus intracranial pressure, but at the cost of cerebral blood flow. Lowering PaCO2 causes cerebral vasoconstriction, which reduces cerebral blood volume and ICP. However, this also reduces blood flow to potentially injured brain tissue, increasing the risk of ischemia if used for too long. Because of that balance, hyperventilation is not used routinely or long-term in severe TBI. It is reserved as a temporary, crisis-management maneuver when there are signs of impending herniation, to rapidly lower ICP while definitive therapies are pursued. The typical target in this urgent setting is a PaCO2 of about 30–35 mmHg for a short duration, after which ventilation is normalized to avoid ongoing ischemic risk.